STERIS plc vs Abbvie Inc.
STE vs ABBV — side-by-side comparison from reported financials. STE leads 7, ABBV leads 5 of 12 comparable metrics.
STERIS plc
STE · Healthcare
$214.40+1.73%Strong
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | STE | ABBV |
|---|---|---|
| Price | $214.40 | $276.43 |
| Market cap | $20.9B | $488B |
| Revenue (TTM) | $6.04B | $64.4B |
| Revenue growth | +6.2% | +1.8% |
| Net margin | 13.3% | 9.8% |
| Free cash flow | $926M | $18.2B |
| Net cash (debt) | ($1.65B) | ($56.2B) |
| 1-year price return | -10.5% | +19.8% |
| P/E | 26.0 | 77.4 |
| P/E vs own history (cheap-side %) | 97% | 23% |
| Dividend yield | 1.18% | 2.45% |
| Return on equity | 11% | 96% |
| Altman Z-score | 4.34 | 2.33 |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 17,937 | 57,000 |
Full résumé-style profiles: STE CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.